Author

Cameron Fraser

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Kristopher A. SarosiekiD· 2 shared Adam G. PresseriD· 1 shared Adam Presser· 1 shared Bo R. RuedaiD· 1 shared Brendan Shay· 1 shared Daohong ZhouiD· 1 shared David S. Garvey· 1 shared Elizabeth H. StoveriD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Kristopher A. SarosiekORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A peptide-based screen for cell death inhibitors identifies the cytoprotective compound CDL36

Zintis Inde, Sebastian Keppler, Jesse D. Gelles, Cameron Fraser, Adam Presser, Jarvier N. Mohammed, May Jung, David S. Garvey, Tudor Moldoveanu, Jerry E. Chipuk, Kristopher A. Sarosiek

The paper identifies CDL36, a compound that inhibits cell death by preventing mitochondrial outer membrane permeabilization, with potent cytoprotection against doxorubicin-induced toxicity.

bioRxiv · Jul 10, 2026 · PreprintMolecular Biology

Quantifying Somatic Mutation Burden: An Assay Validation Framework and Implementation in SomaticCODEC

Joshua N. Johnstone, James Phie, Cameron Fraser

The paper introduces a framework for validating somatic mutation burden assays using relative validation and secondary metrics, implemented in SomaticCODEC with strong linearity and precision in human samples.

bioRxiv · May 5, 2026 · PreprintGenomics

Paclitaxel-induced mitotic arrest results in a convergence of apoptotic dependencies that can be safely exploited by BCL-XL degradation to overcome cancer chemoresistance

Xingping Qin, Adam G. Presser, Lissah Johnson, Yusuke Matoba, Brendan Shay, Weiyi Xu, Jonathan Choiniere, Cameron Fraser, Filip Garbicz, Johan K. E. Spetz, Stacey J. Yu, Mary H.C. Florido, Francesca Picucci, Yang Yang, Ronny Drapkin, , Kristopher A. Sarosiek

bioRxiv · Jun 24, 2025 · PreprintCancer Biology